607 related articles for article (PubMed ID: 14593001)
21. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
[TBL] [Abstract][Full Text] [Related]
22. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.
Sekar N; Veldhuis JD
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783
[TBL] [Abstract][Full Text] [Related]
24. Enhanced binding of Sp1/Sp3 transcription factors mediates the hyperoxia-induced increased expression of the lung type I cell gene T1alpha.
Cao YX; Ramirez MI; Williams MC
J Cell Biochem; 2003 Aug; 89(5):887-901. PubMed ID: 12874823
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
26. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4.
Montessuit C; Rosenblatt-Velin N; Papageorgiou I; Campos L; Pellieux C; Palma T; Lerch R
Cardiovasc Res; 2004 Oct; 64(1):94-104. PubMed ID: 15364617
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
28. Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells.
Akiyama H; Tanaka T; Maeno T; Kanai H; Kimura Y; Kishi S; Kurabayashi M
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1367-74. PubMed ID: 11980848
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
30. Involvement of Sp1 binding sequences in basal transcription of the rat fibroblast growth factor-2 gene in neonatal cardiomyocytes.
Tang W; Pan Q; Sun F; Ma J; Tang S; Le K; Wan Y; Chen Q; Liu P
Life Sci; 2009 Mar; 84(13-14):421-7. PubMed ID: 19302822
[TBL] [Abstract][Full Text] [Related]
31. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
Inoue S; Oishi M
Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
[TBL] [Abstract][Full Text] [Related]
32. Sp1 and Sp3 regulate basal transcription of the survivin gene.
Xu R; Zhang P; Huang J; Ge S; Lu J; Qian G
Biochem Biophys Res Commun; 2007 Apr; 356(1):286-92. PubMed ID: 17350596
[TBL] [Abstract][Full Text] [Related]
33. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
34. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
[TBL] [Abstract][Full Text] [Related]
35. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
37. NKX2.1 regulates transcription of the gene for human bone morphogenetic protein-4 in lung epithelial cells.
Zhu NL; Li C; Xiao J; Minoo P
Gene; 2004 Feb; 327(1):25-36. PubMed ID: 14960358
[TBL] [Abstract][Full Text] [Related]
38. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
39. B-MYB transactivates its own promoter through SP1-binding sites.
Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
[TBL] [Abstract][Full Text] [Related]
40. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
